Rapid antibiotic desensitization is a type of induction of tolerance by which patients with IgE-mediated allergies to antibiotics may safely receive these drugs. Only patients with type I allergy are candidates for this procedure. Rapid desensitization is intended for clinical situations in which there is an absolute need for an antibiotic and alternate noncross-reacting antibiotics cannot be substituted. Desensitization protocols involve stepwise administration of gradually increasing doses of the antibiotic, starting at a sub-allergenic dose and progressing to the full dose. Successful antibiotic desensitization has been described via the oral, intravenous, intramuscular and inhaled routes. Penicillin desensitization has the longest and largest published body of evidence, but similar regimens have been successfully applied to virtually every other class of antibiotics. Antibiotic desensitization is a relatively safe procedure, and allergic reactions occur in a minority of patients; the vast majority of individuals are able to complete the procedure. Patients undergoing desensitization need to be continually monitored, and medical staff in attendance should be able to rapidly treat potential anaphylaxis. Graded challenge differs from desensitization because the immune response to an antibiotic is not modified. Patients who are unlikely to be allergic to an antibiotic are candidates for graded challenge, whereas desensitization is indicated for those who probably have IgE-mediated allergy.